Full Text View
Tabular View
No Study Results Posted
Related Studies
Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
This study is currently recruiting participants.
Verified March 2013 by Massachusetts General Hospital
Study NCT00712426   Information provided by Massachusetts General Hospital

First Received on July 8, 2008.   Last Updated on March 21, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Huntington's Disease
Additional conditions recognized in this trial
Huntington Disease
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Chorea
Cognition Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Dementia
Dyskinesias
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Mental Disorders
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Interventions listed in this trial
Creatine Monohydrate
Placebo
Sponsors listed in this trial
Massachusetts General Hospital
University of Rochester
National Center for Complementary and Alternative Medicine (NCCAM)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services